Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System

Autor: Andersen O, Ernberg I, Hedström AK

Publikováno v: Infection and Drug Resistance, Vol Volume 16, Pp 4599-4620 (2023)

Oluf Andersen,1 Ingemar Ernberg,2 Anna Karin Hedström3 1Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 2Department of Microbiology, Tumor and Cell Bio

Externí odkaz: https://doaj.org/article/800364947788433baa23d1ecc802f3f4

Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.

Autor: Huang J; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden., Tengvall K; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, SE 751 23 Uppsala, Sweden., Lima IB; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden., Hedström AK; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Butt J; Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), DE-69120 Heidelberg, Germany., Brenner N; Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), DE-69120 Heidelberg, Germany., Gyllenberg A; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden., Stridh P; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden., Khademi M; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden., Ernberg I; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Al Nimer F; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden., Manouchehrinia A; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden., Hillert J; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Alfredsson L; Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centre for Occupational and Environmental Medicine, Stockholm County Council, SE-171 77 Stockholm, Sweden., Andersen O; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburgh, Sweden., Sundström P; Department of Clinical Science, Neurosciences, Umeå University, SE-901 85 Umeå, Sweden., Waterboer T; Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), DE-69120 Heidelberg, Germany., Olsson T; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden., Kockum I; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Centrum for Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.

Publikováno v: Brain : a journal of neurology [Brain] 2024 Oct 03; Vol. 147 (10), pp. 3573-3582.

Reply.

Autor: Alfredsson L; Karolinska Institutet, Centre for Occupational and Environmental Medicine, Region Stockholm, Stockholm, Sweden., Klareskog L; Karolinska Institutet at Karolinska University Hospital, Solna, Stockholm, Sweden., Hedström AK; Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Mar; Vol. 76 (3), pp. 487-488. Date of Electronic Publication: 2023 Oct 26.

Association between sun exposure habits and disease progression in multiple sclerosis.

Autor: Wu J; Department of Neurobiology, Care Sciences and Society, Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden., Olsson T; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Alfredsson L; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Centre for Occupational and Environmental Medicine, Region Stockholm, Stockholm, Sweden., Hedström AK; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: European journal of neurology [Eur J Neurol] 2024 Jun; Vol. 31 (6), pp. e16269. Date of Electronic Publication: 2024 Mar 05.

Influence of Smoking on Disease Activity and Quality of Life in Patients With Rheumatoid Arthritis: Results From a Swedish Case-Control Study With Longitudinal Follow-Up.

Autor: Alfredsson L; Karolinska Institutet, Stockholm, Sweden., Klareskog L; Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Hedström AK; Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Arthritis care & research [Arthritis Care Res (Hoboken)] 2023 Jun; Vol. 75 (6), pp. 1269-1277. Date of Electronic Publication: 2023 Jan 16.